Otsuka America Pharmaceutical, Inc. (OAPI) is part of the Otsuka Group (Otsuka).
OAPI was established in the U.S. in 1989 and is responsible for all pharmaceutical and medical device commercial activities in North America. OAPI's corporate objective is to be a strong, highly competitive organization, focused on both our customers and top-line growth, continuing to successfully launch products for better patient outcomes.
OAPI has been highly successful in commercializing Otsuka-developed and in-licensed products, including products from Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), a U.S.-based sister company. To learn more about OAPI's marketed products, click here.
Over the past two years, OAPI has increased its sales presence in the Neuroscience, Hospital, Oncology and Medical Device marketplaces. OAPI's specialized sales forces are on track to exceed 2011 performance expectations.
OAPI is committed to its nearly 700 employees. In 2010, the organization advanced its commitment to develop its people through structured Individual Development Plans. More recently, the company introduced a comprehensive, flexible career pathways initiative to its Sales organization. OAPI seeks to be a magnet for talent, a place where the best employees choose to work.